Detalles de la búsqueda
1.
A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
BJU Int
; 121(4): 647-658, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29044968
2.
Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study.
World J Urol
; 35(3): 421-427, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27334136
3.
Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart(®) ) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment-naïve men with moderately symptomatic benign prostatic hyperplasia: 2-year CONDUCT study results.
BJU Int
; 116(3): 450-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25565364
4.
Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study.
Eur Urol Open Sci
; 45: 59-67, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36353657
5.
Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review.
Endocr Connect
; 11(12)2022 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36283120
6.
Patients and physician satisfaction of Degarelix in androgen deprivation therapy for advanced hormone-dependent prostate cancer in the Netherlands.
Curr Urol
; 15(4): 204-208, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35069083
7.
Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi).
Eur Urol Open Sci
; 28: 52-61, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34337526
8.
The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis.
Springerplus
; 5: 653, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27330919
Resultados
1 -
8
de 8
1
Próxima >
>>